Results 111 to 120 of about 22,145 (200)

Engineered PD1-NKG2D Dual-CAR NK92 cells broaden antitumor target recognition in preclinical tumor models. [PDF]

open access: yesJ Transl Med
Jin X   +8 more
europepmc   +1 more source

Targeting the NKG2D axis in head and neck squamous cell carcinoma: from molecular insights to clinical applications. [PDF]

open access: yesCancer Cell Int
Alijanizadeh P   +8 more
europepmc   +1 more source

Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms. [PDF]

open access: yesCancers (Basel)
Shivarov V   +6 more
europepmc   +1 more source

Challenges and Opportunities of γδ T Cell-Based Immunotherapy for Glioblastoma. [PDF]

open access: yesBiomedicines
Chao CC   +5 more
europepmc   +1 more source

Dual role for NKG2D [PDF]

open access: yesNature Reviews Immunology, 2003
openaire   +1 more source

Home - About - Disclaimer - Privacy